Experiment: 8VSX

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.75 mM [U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
2	3D HNCO	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
3	3D HNCACB	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
9	3D HNCACBi	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
4	3D HNCA	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
5	3D CBCA(CO)NH	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
8	3D HN(COCA)CB	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
7	3D HBHA(CO)NH	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
6	3D HBHANH	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
10	2D (HB)CB(CGCD)HD	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
14	2D HBCBCGCDCEHE	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
13	2D 1H-13C HSQC aliphatic	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 800
12	3D HCCH-TOCSY	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 800
11	3D C(CO)NH	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 600
15	3D 1H-13C NOESY aliphatic	0.75 mM [U-100% 13C; U-100% 15N] Guanylyl Cyclase Activating Protein-5 (GCAP5) with R22A Mutation, 5 mM [U-99% 2H] TRIS-d11, 2 mM [U-99% 2H] DTT-d10	93% H2O/7% D2O	5 mM	7.4	1 atm	305	Bruker AVANCE III 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600
2	Bruker	AVANCE III	800

NMR Refinement
Method	Details	Software
DGSA-distance geometry simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	500
Conformers Submitted Total Number	10
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	chemical shift assignment	NMRFAM-SPARKY		Lee W, Tonelli M, Markley JL
3	data analysis	NMRFAM-SPARKY		Lee W, Tonelli M, Markley JL
4	structure calculation	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
5	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.